Scarica l'app Stockscreener
10.32
3.10%
0.31
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AVTR Giù?
Forum
Previsione
Precedente Chiudi:
$10.01
Aprire:
$10.1
Volume 24 ore:
8.32M
Relative Volume:
0.89
Capitalizzazione di mercato:
$7.05B
Reddito:
$6.55B
Utile/perdita netta:
$-551.40M
Rapporto P/E:
-12.77
EPS:
-0.8082
Flusso di cassa netto:
$438.90M
1 W Prestazione:
+2.38%
1M Prestazione:
+14.79%
6M Prestazione:
-9.95%
1 anno Prestazione:
-25.70%
Intervallo 1D:
$10.05
$10.32
Intervallo di 1 settimana:
$9.78
$10.40
Portata 52W:
$7.265
$15.93
Avantor Inc Stock (AVTR) Company Profile
Nome
Avantor Inc
Settore
Industria
Telefono
(610) 386-1700
Indirizzo
RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA
Compare AVTR vs ISRG, BDX, MDLN, ALC, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVTR
Avantor Inc
|
10.32 | 6.76B | 6.55B | -551.40M | 438.90M | -0.8082 |
ISRG
Intuitive Surgical Inc
|
426.01 | 140.84B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
158.08 | 41.70B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
43.19 | 33.35B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
69.66 | 32.72B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
209.63 | 28.27B | 5.54B | 1.52B | 1.74B | 10.37 |
Avantor Inc Stock (AVTR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-06 | Downgrade | Barclays | Equal Weight → Underweight |
| 2026-01-05 | Downgrade | Evercore ISI | Outperform → In-line |
| 2025-12-17 | Downgrade | Jefferies | Hold → Underperform |
| 2025-12-15 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-11-04 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2025-10-30 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-10-30 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-08-01 | Downgrade | Jefferies | Buy → Hold |
| 2025-04-29 | Downgrade | Goldman | Buy → Neutral |
| 2025-04-28 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-04-28 | Downgrade | Stifel | Buy → Hold |
| 2025-04-28 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-17 | Downgrade | UBS | Buy → Neutral |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-07-10 | Downgrade | Citigroup | Buy → Neutral |
| 2024-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-12-11 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-31 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-07-31 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-06-21 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-12-14 | Iniziato | Deutsche Bank | Hold |
| 2022-10-05 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-09-14 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-09-09 | Downgrade | Cleveland Research | Buy → Neutral |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-04 | Downgrade | Citigroup | Buy → Neutral |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-30 | Ripresa | Raymond James | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-08-02 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-06-04 | Iniziato | Goldman | Buy |
| 2021-04-29 | Aggiornamento | Stifel | Hold → Buy |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-08-02 | Iniziato | Cleveland Research | Neutral |
| 2019-06-14 | Iniziato | Janney | Buy |
| 2019-06-12 | Iniziato | Raymond James | Outperform |
| 2019-06-11 | Iniziato | Goldman | Buy |
| 2019-06-11 | Iniziato | Guggenheim | Buy |
| 2019-06-11 | Iniziato | JP Morgan | Overweight |
| 2019-06-11 | Iniziato | Jefferies | Buy |
| 2019-06-11 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2019-06-11 | Iniziato | Piper Jaffray | Neutral |
| 2019-06-11 | Iniziato | RBC Capital Mkts | Outperform |
| 2019-06-11 | Iniziato | Robert W. Baird | Outperform |
| 2019-06-11 | Iniziato | SunTrust | Buy |
| 2019-06-11 | Iniziato | UBS | Buy |
| 2019-06-11 | Iniziato | William Blair | Outperform |
Mostra tutto
Avantor Inc Borsa (AVTR) Ultime notizie
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Investors to Inquire about Securities Investigation - ACCESS Newswire
Avantor® to Report Second Quarter 2026 Earnings on Wednesday, July 29, 2026 - BioSpace
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Join Class Action to Recover Losses from Avantor, Inc. (AVTR) – Contact Levi & Korsinsky Before December 29, 2025 - The National Law Review
Smart Money Is Buying Avantor Inc (AVTR) - The Acquirer's Multiple
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Avantor, Inc. (AVTR) Stock Analysis: Navigating Potential Upside Amidst Market Challenges - DirectorsTalk Interviews
Did You Lose Money on Avantor, Inc. (AVTR)? Levi & Korsinsky Urges Investors to Act Before December 29, 2025 - The National Law Review
Class Action Filed Against Avantor, Inc. (AVTR) Over Securities ViolationsContact Levi & Korsinsky Today - The National Law Review
Investors in Avantor, Inc. (AVTR): Protect Your RightsContact Levi & Korsinsky Before December 29, 2025 - The National Law Review
Securities Fraud Class Action Filed Against Avantor, Inc. (AVTR) - The National Law Review
J.T.Baker BAKERBOND ABx05 resin from Avantor Inc.single-use columns for tighter mAb polishing - Ad-hoc-news.de
Avantor (NYSE:AVTR) Rebound Puts Valuation Debate Back In Focus - Kalkine Media
Avantor shares drop more than 5% as turnaround efforts fail to excite investors - MSN
Bernstein Maintains Avantor(AVTR.US) With Hold Rating, Cuts Target Price to $10.5 - Moomoo
Bernstein resumes Avantor stock coverage with Market Perform rating - Investing.com
Bernstein resumes Avantor stock coverage with Market Perform rating By Investing.com - Investing.com Canada
Avantor, Inc. Actuals & Estimates (NYSE:AVTR) - TradingView
Avantor Inc (AVTR) Shares Surge 4.0% -- What GF Score of 61 Tells Investors - GuruFocus
Why Avantor (AVTR) Stock Is Up Today - Yahoo Finance
AVTR Forecast — Price Target — Prediction for 2027 - TradingView
Avantor Inc earnings calendar and analyst views, shares on NASDAQ watch - AD HOC NEWS
Price to earnings forward of Avantor, Inc. – NYSE:AVTR - TradingView
Price to sales forward of Avantor, Inc. – NYSE:AVTR - TradingView
Price to earnings forward of Avantor, Inc. – XETR:AVG - TradingView
Enterprise value to EBITDA forward of Avantor, Inc. – XETR:AVG - TradingView
Enterprise value to EBIT forward of Avantor, Inc. – NYSE:AVTR - TradingView
Price to book forward of Avantor, Inc. – XETR:AVG - TradingView
How Avantor Inc. (AVTR) Affects Rotational Strategy Timing - Stock Traders Daily
Barclays Maintains Avantor(AVTR.US) With Sell Rating, Raises Target Price to $8 - Moomoo
Avantor Inc (AVTR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Investors to Reach Out - ACCESS Newswire
2026-06-23 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Investors to Reach Out | NYSE:AVTR | Press Release - Stockhouse
Form 4 Avantor Inc For: 22 June By Investing.com - Investing.com Nigeria
Avantor (AVTR) executive has shares withheld to cover RSU taxes - Stock Titan
Avantor refocuses on biopharma and lab services, shares in S&P 500 health tech cohort spotlight - AD HOC NEWS
Avantor, Inc. (AVTR) Stock Analysis: A Healthcare Giant with Limited Upside and Mixed Ratings - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Stockholders to Reach Out - ACCESS Newswire
Why Avantor’s J.T.Baker BAKERBOND ABx resin is drawing quiet attention in bioprocessing labs - AD HOC NEWS
What Avantor (AVTR)'s Wolfe Underperform Call Means For Shareholders - simplywall.st
Q1 Rundown: Avantor (NYSE:AVTR) Vs Other Research Tools & Consumables Stocks - Yahoo Finance
Why Avantor J.T.Baker BAKERBOND ABx Pro columns aim for cleaner bioprocessing - AD HOC NEWS
Avantor Inc (AVTR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Avantor Inc (AVTR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Avantor Inc (AVTR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Avantor Inc (AVTR) Institutional Confidence - TradingKey
Avantor Inc (AVTR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Avantor Inc (AVTR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Avantor Inc (AVTR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Avantor Inc (AVTR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Avantor (AVTR) Gets Underperform Rating From Wolfe Research - Yahoo Finance
Avantor Inc Azioni (AVTR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Avantor Inc Azioni (AVTR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Dingemans Simon | Director |
May 01 '26 |
Buy |
8.14 |
25,000 |
203,500 |
25,000 |
| MEHRA SANJEEV K | Director |
Mar 10 '26 |
Buy |
8.01 |
125,000 |
1,001,250 |
475,000 |
| LUCIER GREGORY T | Director |
Feb 19 '26 |
Buy |
9.16 |
50,000 |
458,000 |
50,000 |
| SUMME GREGORY L | Director |
Feb 12 '26 |
Buy |
9.40 |
100,000 |
940,000 |
400,000 |
| MEHRA SANJEEV K | Director |
Dec 05 '25 |
Buy |
11.09 |
350,000 |
3,881,500 |
350,000 |
| Ligner Emmanuel | President and CEO |
Nov 17 '25 |
Buy |
11.35 |
87,500 |
993,125 |
283,424 |
4.43%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):